Preventing Cognitive and Neural System Deterioration in Early Psychosis

Sophia Vinogradov, M.D.

Introduction

Sophia Vinogradov, MD is the Donald W. Hastings Endowed Chair in Psychiatry and Department Head of Psychiatry at the University of Minnesota Medical School. She was previously the Vice-Chair of the Department of Psychiatry at the University of California, San Francisco, and Associate Chief of Staff for Mental Health at the San Francisco VA Medical Center. She received her M.D. from Wayne State University School of Medicine, obtained her psychiatry residency training at Stanford University School of Medicine, where she served as Chief Resident, and completed a Psychiatric Neurosciences Research Fellowship at the Palo Alto VA Medical Center and Stanford University.

Dr. Vinogradov directs a translational clinical neuroscience laboratory that focuses on cognitive dysfunction in schizophrenia. In collaboration with basic scientists, she studies neuroscience-informed computerized cognitive training exercises for patients with schizophrenia that aim to drive enduring plastic changes in cortical processing. Dr. Vinogradov uses MEG and fMRI methods to probe the brain changes in both early sensory processing and higher-order cognitive operations in subjects who undergo this cognitive training. More recently, she has begun to apply these methods to the study of adolescents who are prodromal for schizophrenia and young adults in early psychosis, with the goal of delaying or preventing the onset of a deteriorating psychiatric illness. Her work has contributed to a growing interest in the use of computerized “brain training” to treat some of the brain information processing abnormalities of psychiatric illnesses, and she was a participant at the White House conference on “Video Games to Enhance Attention and Well-Being.”

Learning Objectives

1. The audience will become familiar with typical profile of cognitive deficit in early phases of psychotic illness.
2. The audience will become familiar with the principles of neuroscience-informed cognitive training.
3. The audience will become familiar with the effects of target cognitive training in early phases of psychotic illness. 

 
Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu.

Credit Statements
• Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
• Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
• The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.
• Archived webcast available at: Psychiatry & Psychology Video Library
Industry Acknowledgment (if applicable): None.

NEW in 2017 !!!

All participants MUST complete the evaluation in order to get CME or APA Credit. 

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.
 
Disclosure Summary
As a provider accredited by ACCME, Mayo Clinic College of Medicine and Science (Mayo CLINIC School of Continuous Professional Development), must ensure balance, independence, objectivity and scientific rigor in its educational activities.   Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry: 

Speaker Sophia Vinogradov, M.D., Grant/Research Support:  Posit Science, Inc.

No relevant financial relationship(s) with industry:
Brian Palmer, M.D., Michael Bostwick, M.D., Karen Grothe, Ph.D., Lois Krahn, M.D., Jarrod Leffler, Ph.D., Larissa Loukianova, M.D., Mary Machulda, Ph.D., Patricia Maus, RN, M.S., Jeffrey Staab, M.D., Cosima Swintak, M.D., Kristin Vickers Douglas, Ph.D., Cynthia Harbeck-Weber, Ph.D., Michael Zaccariello, Ph.D., Charlene Nelson

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:  NONE